Literature DB >> 2530779

Metabolic pathway of paroxetine in animals and man and the comparative pharmacological properties of its metabolites.

R E Haddock1, A M Johnson, P F Langley, D R Nelson, J A Pope, D R Thomas, F R Woods.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2530779     DOI： 10.1111/j.1600-0447.1989.tb07163.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand Suppl        ISSN： 0065-1591


× No keyword cloud information.
  17 in total

Review 1.  Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors.

Authors:  C L DeVane
Journal:  Cell Mol Neurobiol       Date:  1999-08       Impact factor: 5.046

Review 2.  The impact of the CYP2D6-polymorphism on dose recommendations for current antidepressants.

Authors:  Norbert Thuerauf; Jens Lunkenheimer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-08       Impact factor: 5.270

3.  A mathematical model for paroxetine antidepressant effect time course and its interaction with pindolol.

Authors:  Berangere Gruwez; Alain Dauphin; Michel Tod
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-12       Impact factor: 2.745

Review 4.  Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.

Authors:  N S Gunasekara; S Noble; P Benfield
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

Review 5.  Paroxetine. A review of its pharmacology, therapeutic use in depression and therapeutic potential in diabetic neuropathy.

Authors:  S M Holliday; G L Plosker
Journal:  Drugs Aging       Date:  1993 May-Jun       Impact factor: 3.923

6.  The role of cytochrome P4502D6 in the metabolism of paroxetine by human liver microsomes.

Authors:  J C Bloomer; F R Woods; R E Haddock; M S Lennard; G T Tucker
Journal:  Br J Clin Pharmacol       Date:  1992-05       Impact factor: 4.335

7.  The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.

Authors:  H K Crewe; M S Lennard; G T Tucker; F R Woods; R E Haddock
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335

8.  Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.

Authors:  R H Foster; K L Goa
Journal:  CNS Drugs       Date:  1997-08       Impact factor: 5.749

Review 9.  Clinical pharmacokinetics of selective serotonin reuptake inhibitors.

Authors:  J van Harten
Journal:  Clin Pharmacokinet       Date:  1993-03       Impact factor: 6.447

Review 10.  New formulations of existing antidepressants: advantages in the management of depression.

Authors:  Trevor R Norman; James S Olver
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.